Skip to main content

National Institutes of Health

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Active

Decision brief

Who can apply
Higher EducationSmall BusinessGovernmentNonprofitsOtherNonprofits (preferred)
Award amount
Up to $500K
Deadline
Jan 7, 2028
Geography
National
Application notesMedium effort
  • Federal application

Next step

Apply at Grants.gov

Apply Now

Focus areas

About this grant

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.

Additional details

CFDA / ALN Number
93.393
Program Title
Cancer Cause and Prevention Research
Estimated Total Funding
Up to $500K
Funding Instrument
Grant
Source
Grants.gov · View original listing

Similar grants